Berberine safety: side effects, interactions and who should avoid it

What the safety record covers, and what it doesn't

Berberine is sold as an ordinary supplement, but it is a biologically active compound with real pharmacology. Most of what is known about its safety comes from trials of a few months at doses between 400 mg and 1.5 g a day, usually in people with a metabolic or digestive condition. That is not the same as the long-term daily use many people have in mind.

The trials that report on tolerability are mostly reassuring at a glance. A 12-week trial in 84 men with high cholesterol used 1,000 mg a day and reported no serious adverse events (PMID 34444711). An 8-week trial in people with diarrhea-predominant irritable bowel syndrome used 400 mg a day of berberine hydrochloride and described it as well tolerated (PMID 26400188).

Those findings come with limits. The trials are small, short and selected, and they are not designed to detect rare events. A 2023 or 2026 headline about "no serious side effects" in a few dozen people says little about the one-in-a-thousand problem, which is where the heart-rhythm and drug-interaction concerns below sit.

Longer exposure exists in the literature: one trial gave 600 mg a day for up to two years to adults who had colon polyps removed, and found fewer new polyps than placebo (PMID 31926918). The summary available to us reports polyp outcomes rather than a full safety analysis, so it is hard to treat it as a verdict on long-term safety. For a broader overview, see our berberine topic page.

Digestive side effects: the most common complaint

Diarrhea, constipation, cramping and nausea are the side effects reported most consistently. In one three-month trial at 1.5 g a day, split into three 500 mg doses, about a third of participants (34.5%) had transient gastrointestinal effects, mainly diarrhea, that eased as the study went on. A phase I trial of 900 mg a day in 12 people with ulcerative colitis recorded one case of nausea (PMID 31619442).

Why berberine upsets the gut is not settled. One review describes its effects as partly mediated by changes in gut bacteria, including a bacteriostatic action that suppresses some populations rather than adding live ones (PMID 32105754). Whether that explains the cramping and loose stools is an inference, not a demonstrated link.

Dose probably matters, though no trial we have seen compares digestive tolerability across doses head to head. If you are prone to stomach upset, taking a capsule with a meal is a common practical step. That advice is general; we found no berberine-specific study testing food timing.

We found no solid documentation in the sources reviewed for headaches, fatigue, hair loss or dry mouth as berberine effects. Absence of documentation is not proof of absence, so any new symptom after starting is worth noting.

Drug and supplement interactions

This is the area where berberine's safety profile is least intuitive. A 2026 review found that although very little berberine reaches the bloodstream, it still interacts with the machinery the body uses to handle other drugs (PMID 42653808). It inhibits and, in some cases, induces the enzyme CYP3A4, inhibits CYP2D6 and CYP2C9, and alters drug transporters including P-glycoprotein, OCT1, OCT2 and MATE1.

The clearest human example involves cyclosporine, an anti-rejection drug. In people who had received a kidney transplant, berberine raised cyclosporine exposure by 34.5%. For a drug with a narrow margin between effective and toxic levels, that is a meaningful shift. Anyone on cyclosporine, or a similarly sensitive medication, should not add berberine without medical supervision.

The review also found additive effects with blood-sugar-lowering medication. That covers metformin, insulin and sulfonylurea-type drugs. Berberine lowers glucose on its own, so stacking it on top of these drugs can push blood sugar lower than intended, and the interaction is not necessarily proportional to dose.

Medications that affect heart rhythm are flagged as a theoretical additive risk, based on berberine's pharmacology and the cardiac signals described below. Berberine is not classified as a blood thinner, and we found no research documenting an effect on clotting, but anyone on an anticoagulant should still ask before adding any new supplement.

For other supplements and for alcohol, the honest answer is that dedicated interaction data are sparse. We found no study on berberine and alcohol, and no well-documented supplement-to-supplement interactions. Tell a pharmacist about everything you take. Our guide to berberine and medications covers the same ground in more detail.

One further complication is product variability. The same 2026 review notes that marketed berberine products differ in how closely the labeled amount matches the contents. Formulation matters too: a berberine phytosome produced roughly 10 times higher blood berberine levels than unformulated berberine in healthy volunteers (PMID 34904017), and in five healthy men 100–200 mg of dihydroberberine gave higher blood levels than 500 mg of plain berberine (PMID 35010998). Most safety data come from plain berberine, so milligrams are not interchangeable across forms. That is our inference from the absorption data, not a tested safety finding.

Heart rhythm and blood pressure

Berberine is often discussed for its cardiometabolic effects, which makes the cardiac safety signal easy to miss. A 2026 systematic review of 22 studies noted that, alongside antiarrhythmic mechanisms seen in lab and animal models, berberine is documented to cause QT-interval prolongation, slowed heart rate (bradycardia) and low blood pressure in some cases (PMID 40248925).

A 2026 case report gives the concern a human face. A 92-year-old man developed torsades de pointes, a life-threatening rhythm abnormality, with a markedly prolonged QT interval about two weeks after starting a berberine supplement. His rhythm normalized after he stopped it (PMID 42647909).

A single case in a very old man cannot tell us how common this is, and it cannot prove berberine was the sole cause. It is still the kind of event that justifies caution. People with a known long QT interval, a slow heart rate, low blood pressure, or a prescription that affects heart rhythm should ask a doctor before starting.

The liver question: mostly reassuring, with exceptions

The liver evidence is mixed in an interesting way. The LiverTox database states that berberine has not been linked to liver-enzyme elevations or clinically apparent liver injury during typical use (PMID 33242239). A 2020 meta-analysis of 12 randomized trials found no significant effect on the standard liver tests ALT and AST (PMID 32690176). In 811 people with fatty liver disease, a 2024 meta-analysis found berberine lowered ALT, AST and GGT, with only mild digestive side effects (PMID 38429794).

There are two flags. In the small phase I ulcerative colitis trial at 900 mg a day for three months, one of 12 participants had a grade 3 transaminase elevation judged possibly treatment-related (PMID 31619442). That is a single event in a tiny sample, but it is a reminder that rare reactions are not ruled out.

Separately, a 2024 mouse study found 30 days of oral berberine worsened liver inflammation and fibrosis in mice carrying the mutation behind alpha-1 antitrypsin deficiency, but not in normal mice (PMID 39298444). It is animal data, and nobody has tested the question in people. Still, anyone with an inherited or existing liver condition has reason to ask a clinician first.

Who should avoid berberine or ask first

The firmest rule is pregnancy and nursing. A laboratory and animal study found berberine displaces bilirubin from the blood protein that normally carries it (PMID 8513024). That is why berberine-containing herbs are advised against in pregnancy and in newborns, where free bilirubin is a particular concern. The data are not human outcome data, but the caution is long-standing and applies at any dose.

Children and teenagers are on the list for a simple reason: no one has established a safe dose for them. Kidney and liver disease are on it because berberine is processed by drug-metabolizing enzymes and cleared partly through these organs, and how it behaves with reduced function is unstudied. Our piece on who should not take berberine walks through each caution.

Warning signs to stop and get help

Some signs are less dramatic but still warrant stopping and calling a clinician or pharmacist:

• Severe or persistent diarrhea, vomiting or abdominal pain that does not ease after the first days.
• Lightheadedness, shakiness, sweating or confusion, especially if you take diabetes medication, since these can reflect low blood sugar.
• Yellowing of the skin or eyes, dark urine or pale stools, which are general warning signs of liver trouble, not berberine-specific findings.
• Any new symptom that started soon after you began, and that you cannot otherwise explain.

If you are on prescription medication, the safest sequence is to ask before starting rather than after a problem appears. Bring the product label, and note the amount per serving and the form, since those details change how a pharmacist assesses it.

Reducing risk if you decide to take it

Berberine is not a supplement to take casually alongside a long medication list. Start by checking with a doctor or pharmacist if you take any prescription drug, have a heart, liver or kidney condition, or are pregnant, nursing or under 18.

Choose a product that discloses its form and amount per serving, and do not assume that doubling the dose is harmless. Take only the labeled amount, and watch for digestive effects in the first weeks. Because published data on daily use beyond about six months are thin, it is reasonable to revisit the decision with a clinician periodically rather than treat it as set-and-forget.